Calumet Specialty Products Partners - CLMT Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $23.75
  • Forecasted Upside: 11.50%
  • Number of Analysts: 4
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 4 Buy Ratings
  • 0 Strong Buy Ratings
$21.30
▲ +0.13 (0.61%)

This chart shows the closing price for CLMT by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Calumet Specialty Products Partners Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CLMT and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CLMT

Analyst Price Target is $23.75
▲ +11.50% Upside Potential
This price target is based on 4 analysts offering 12 month price targets for Calumet Specialty Products Partners in the last 3 months. The average price target is $23.75, with a high forecast of $29.00 and a low forecast of $15.00. The average price target represents a 11.50% upside from the last price of $21.30.

This chart shows the closing price for CLMT for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Buy

The current consensus among 4 contributing investment analysts is to buy stock in Calumet Specialty Products Partners. This rating has held steady since December 2023, when it changed from a Moderate Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
7/9/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
10/7/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/5/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/4/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/3/2024
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/1/2024
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/30/2024
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/30/2024

Latest Recommendations

  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
11/11/2024TD CowenLower TargetBuy ➝ Buy$27.00 ➝ $26.00
11/11/2024HC WainwrightReiterated RatingBuy ➝ Buy$25.00 ➝ $25.00
10/21/2024Wells Fargo & CompanyBoost TargetOverweight ➝ Overweight$25.00 ➝ $29.00
10/17/2024HC WainwrightReiterated RatingBuy ➝ Buy$25.00 ➝ $25.00
10/17/2024TD CowenBoost TargetBuy ➝ Buy$22.00 ➝ $27.00
10/7/2024HC WainwrightReiterated RatingBuy ➝ Buy$25.00 ➝ $25.00
8/12/2024HC WainwrightReiterated RatingBuy ➝ Buy$25.00 ➝ $25.00
8/12/2024TD CowenLower TargetBuy ➝ Buy$20.00 ➝ $18.00
8/5/2024The Goldman Sachs GroupLower TargetBuy ➝ Buy$17.00 ➝ $15.00
5/13/2024HC WainwrightReiterated RatingBuy ➝ Buy$25.00
4/22/2024HC WainwrightReiterated RatingBuy ➝ Buy$25.00
3/21/2024The Goldman Sachs GroupLower TargetBuy ➝ Buy$19.00 ➝ $17.00
12/14/2023The Goldman Sachs GroupBoost TargetBuy ➝ Buy$17.00 ➝ $19.00
10/31/2023The Goldman Sachs GroupLower TargetBuy ➝ Buy$19.00 ➝ $17.00
8/7/2023HC WainwrightReiterated RatingBuy ➝ Buy$25.00
5/15/2023UBS GroupBoost Target$18.50 ➝ $19.50
1/25/2023HC WainwrightLower TargetBuy$28.00 ➝ $25.00
12/13/2022UBS GroupInitiated CoverageNeutral$15.70
8/18/2022The Goldman Sachs GroupUpgradeNeutral ➝ Buy$14.00 ➝ $23.00
6/28/2022CowenBoost TargetOutperform$18.00 ➝ $20.00
5/9/2022CowenBoost Target$18.00 ➝ $20.00
4/21/2022Wells Fargo & CompanyBoost TargetOverweight$27.00 ➝ $29.00
2/28/2022CowenLower TargetOutperform$23.00 ➝ $20.00
2/28/2022HC WainwrightBoost TargetBuy$19.00 ➝ $28.00
1/6/2022Credit Suisse GroupInitiated CoverageNeutral$23.00
11/23/2021Wolfe ResearchUpgradePeer Perform ➝ Outperform$30.00
11/23/2021CowenUpgradeMarket Perform ➝ Outperform$12.00 ➝ $23.00
11/22/2021Wells Fargo & CompanyBoost TargetOverweight$14.00 ➝ $27.00
10/14/2021The Goldman Sachs GroupBoost TargetNeutral$6.00 ➝ $11.00
10/8/2021Wells Fargo & CompanyBoost TargetOverweight$8.00 ➝ $11.00
10/5/2021Wells Fargo & CompanyReiterated RatingOverweight ➝ Market Perform$8.00
10/4/2021HC WainwrightInitiated CoverageBuy$19.00
3/24/2021Wells Fargo & CompanyUpgradeEqual Weight ➝ Overweight$8.00
12/15/2020Wells Fargo & CompanyDowngradeOverweight ➝ Equal Weight$4.00
3/27/2020The Goldman Sachs GroupLower TargetNeutral$2.00 ➝ $1.00
2/11/2020Raymond JamesUpgradeUnderperform ➝ Market Perform
(Data available from 12/30/2019 forward)

News Sentiment Rating

0.60 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 10 very positive mentions
  • 8 positive mentions
  • 4 negative mentions
  • 0 very negative mentions
6/3/2024
  • 3 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/3/2024
  • 3 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/2/2024
  • 7 very positive mentions
  • 13 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
9/1/2024
  • 5 very positive mentions
  • 8 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/1/2024
  • 7 very positive mentions
  • 23 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/31/2024
  • 5 very positive mentions
  • 14 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
11/30/2024
  • 4 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/30/2024

Current Sentiment

  • 4 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Calumet Specialty Products Partners logo
Calumet, Inc. manufactures, formulates, and markets a diversified slate of specialty branded products and renewable fuels to various consumer-facing and industrial markets in North America and internationally. It operates through Specialty Products and Solutions; Montana/Renewables; and Performance brands segments. The Specialty Products and Solutions segment offers various solvents, waxes, customized lubricating oils, white oils, petrolatums, gels, esters, and other products. The Montana/Renewables segment focuses on processing renewable feedstocks into renewable diesel, sustainable aviation fuel, renewable hydrogen, renewable natural gas, renewable propane, and renewable naphtha. It also processes Canadian crude oil into conventional gasoline, diesel, jet fuel, and specialty grades of asphalt. The Performance Brands segment blends, packages, and markets high performance products through Royal Purple, Bel-Ray, and TruFuel brands. The company serves wholesale distributors and retail chains. Calumet, Inc. was founded in 1919 and is headquartered in Indianapolis, Indiana.
Read More

Today's Range

Now: $21.30
Low: $20.64
High: $21.35

50 Day Range

MA: $21.23
Low: $19.60
High: $22.54

52 Week Range

Now: $21.30
Low: $9.97
High: $25.29

Volume

86,782 shs

Average Volume

427,854 shs

Market Capitalization

$1.83 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.91

Frequently Asked Questions

What sell-side analysts currently cover shares of Calumet Specialty Products Partners?

The following Wall Street analysts have issued research reports on Calumet Specialty Products Partners in the last twelve months: HC Wainwright, StockNews.com, TD Cowen, The Goldman Sachs Group, Inc., and Wells Fargo & Company.
View the latest analyst ratings for CLMT.

What is the current price target for Calumet Specialty Products Partners?

0 Wall Street analysts have set twelve-month price targets for Calumet Specialty Products Partners in the last year. Their average twelve-month price target is $23.75, suggesting a possible upside of 11.5%. Wells Fargo & Company has the highest price target set, predicting CLMT will reach $29.00 in the next twelve months. The Goldman Sachs Group, Inc. has the lowest price target set, forecasting a price of $15.00 for Calumet Specialty Products Partners in the next year.
View the latest price targets for CLMT.

What is the current consensus analyst rating for Calumet Specialty Products Partners?

Calumet Specialty Products Partners currently has 4 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe CLMT will outperform the market and that investors should add to their positions of Calumet Specialty Products Partners.
View the latest ratings for CLMT.

What other companies compete with Calumet Specialty Products Partners?

How do I contact Calumet Specialty Products Partners' investor relations team?

Calumet Specialty Products Partners' physical mailing address is 2780 WATERFRONT PARKWAY EAST DRIVE SUITE 200, INDIANAPOLIS IN, 46214. The oil and gas company's listed phone number is (317) 328-5660 and its investor relations email address is [email protected]. The official website for Calumet Specialty Products Partners is www.calumetspecialty.com. Learn More about contacing Calumet Specialty Products Partners investor relations.